Literature DB >> 2271850

New directions in primary biliary cirrhosis.

M C Bateson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2271850      PMCID： PMC1664471          DOI： 10.1136/bmj.301.6764.1290

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  49 in total

1.  A prospective controlled trial of azathioprine in primary biliary cirrhosis.

Authors:  J Heathcote; A Ross; S Sherlock
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

2.  Randomized trial of chlorambucil for primary biliary cirrhosis.

Authors:  J H Hoofnagle; G L Davis; D F Schafer; M Peters; M I Avigan; S C Pappas; R G Hanson; G Y Minuk; G M Dusheiko; G Campbell
Journal:  Gastroenterology       Date:  1986-12       Impact factor: 22.682

3.  Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.

Authors:  J Neuberger; E Christensen; B Portmann; J Caballeria; J Rodes; L Ranek; N Tygstrup; R Williams
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

4.  Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.

Authors:  M C Bateson; I A Bouchier; D B Trash; D P Maudgal; T C Northfield
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

5.  A clinical trial of levamisole in primary biliary cirrhosis.

Authors:  S Hishon; G Tobin; P J Ciclitira
Journal:  Postgrad Med J       Date:  1982-11       Impact factor: 2.401

6.  Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.

Authors:  E Christensen; J Neuberger; J Crowe; D G Altman; H Popper; B Portmann; D Doniach; L Ranek; N Tygstrup; R Williams
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

7.  A prospective trial of colchicine for primary biliary cirrhosis.

Authors:  M M Kaplan; D W Alling; H J Zimmerman; H J Wolfe; R A Sepersky; G S Hirsch; G H Elta; K A Glick; K A Eagen
Journal:  N Engl J Med       Date:  1986-12-04       Impact factor: 91.245

8.  Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

Authors:  R Poupon; Y Chrétien; R E Poupon; F Ballet; Y Calmus; F Darnis
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

9.  Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.

Authors:  U Leuschner; M Leuschner; J Sieratzki; W Kurtz; K Hübner
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

10.  Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes.

Authors:  K Miyazaki; F Nakayama; A Koga
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199
View more
  2 in total

1.  Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum gamma-glutamyltranspeptidase levels.

Authors:  S Kiso; S Kawata; Y Imai; S Tamura; Y Inui; N Ito; Y Matsuzawa
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

2.  Percutaneous hepaticoneojejunostomy and choledochocholedochal reanastomosis using metallic stents: technical note.

Authors:  K Ivancev; B Petersen; L Hall; P Ho; K Benner; J Rösch
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Jul-Aug       Impact factor: 2.740
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.